AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitaglo M Forte 100mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Sitaglo M Forte 100mg/1000mg Tablet SR

This extended-release tablet, containing a dual-action formulation for managing type 2 diabetes, effectively controls elevated blood glucose. By regulating blood sugar, it helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. Prescribed either independently or in conjunction with other diabetes treatments, its efficacy is maximized with a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose readings, and existing medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily usage, at the same time each day, is crucial for optimal results; discontinuation should only occur under medical guidance. Adherence to your physician's dietary and exercise plan is vital for comprehensive diabetes management, as lifestyle significantly impacts blood sugar control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headaches, and sore throat. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require prior medical consultation. Inform your doctor of all medications you are taking, as interactions are possible. Alcohol should be minimized due to its potential to decrease blood glucose levels. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitaglo M Forte 100mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Sitaglo M Forte 100mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Sitaglo M Forte 100mg/1000mg sustained-release tablet should be administered with food.

Common Side effects of Sitaglo M Forte 100mg/1000mg Tablet SR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaglo M Forte 100mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Sitaglo M Forte 100mg/1000mg sustained-release tablet should be taken with a meal.

How Sitaglo M Forte 100mg/1000mg Tablet SR works:

Sitagliptin and metformin, combined as Sitaglo M Forte 100mg/1000mg SR tablets, offer enhanced blood glucose management. Sitagliptin stimulates increased insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, acts by reducing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitaglo M Forte 100mg/1000mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitaglo M Forte 100mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Sitaglo M Forte 100mg/1000mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitaglo M Forte 100mg/1000mg SR tablets. Dosage modification may be necessary; physician consultation is recommended. Sitaglo M Forte 100mg/1000mg SR tablets are contraindicated in patients with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver disease should likely avoid Sitaglo M Forte 100mg/1000mg SR tablets; their use may be unsafe. Medical advice is recommended.

What if you forget to take Sitaglo M Forte 100mg/1000mg Tablet SR :

Should you forget a dose of Sitaglo M Forte 100mg/1000mg sustained-release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaglo M Forte 100mg/1000mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Sitaglo M Forte 100mg/1000mg Tablet SR

Sitagliptin and Metformin, combined as Sitaglo M Forte 100mg/1000mg SR tablets, manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and exercise regimen. Metformin reduces hepatic glucose production and boosts insulin sensitivity. Sitagliptin blocks DPP4, promoting increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Prolonged use of Sitaglo M Forte 100mg/1000mg sustained-release tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Consequently, untreated deficiency may result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental Vitamin B12 is recommended by some studies at least annually.
Sitaglo M Forte 100mg/1000mg sustained-release tablets may cause common adverse events including low blood sugar, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Less frequent, but potentially serious, side effects include lactic acidosis. Prolonged treatment might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo M Forte 100mg/1000mg SR Tablet component or inactive ingredient should not use this medication. Its use is contraindicated in individuals with severely compromised kidney or liver function, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Forte 100mg/1000mg SR tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Maintain this medication within its original, sealed container. Follow the storage guidelines printed on the packaging. Discard any remaining medicine. Prevent access by children, pets, and others.
Sitagliptin/Metformin (Sitaglo M Forte 100mg/1000mg SR) can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid (also known as metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoidance in individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may involve muscular discomfort or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Sitagliptin and Metformin, combined as Sitaglo M Forte 100mg/1000mg SR tablets, manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin, by inhibiting DPP-4, boosts pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo M Forte 100mg/1000mg sustained-release tablets may cause frequent side effects including low blood sugar, taste disturbances, nausea, abdominal pain, loose stools, headache, and upper respiratory infections. Rare but potentially severe adverse reactions such as lactic acidosis are also possible. Prolonged therapy may result in vitamin B12 deficiency.
Patients with hypersensitivity to any constituent of Sitaglo M Forte 100mg/1000mg SR tablets should not use this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Consuming alcohol concurrently with Sitaglo M Forte 100mg/1000mg SR tablets is unsafe due to the heightened risk of lactic acidosis.
Sitaglo M Forte 100mg/1000mg SR tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with kidney impairment, advanced age, or significant alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged use of Sitaglo M Forte 100mg/1000mg SR tablets can lead to vitamin B12 deficiency due to impaired intestinal absorption of the vitamin. This deficiency, if left unaddressed, may manifest as anemia and neurological complications, including peripheral neuropathy (tingling and numbness in extremities), muscle weakness, urinary dysfunction, cognitive changes, and ataxia (balance difficulties). To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some studies.
Maintain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitagliptin and Metformin, combined as Sitaglo M Forte 100mg/1000mg SR tablets, manage type 2 diabetes mellitus in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Metformin reduces hepatic glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4, thus boosting pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitaglo M Forte 100mg/1000mg SR tablets may cause common adverse reactions including low blood sugar, taste disturbances, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects such as lactic acidosis are also possible. Prolonged administration might result in vitamin B12 deficiency.
Patients with hypersensitivity to any Sitaglo M Forte 100mg/1000mg SR Tablet component or inactive ingredient should not use this medication. Furthermore, its administration is contraindicated in individuals experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaglo M Forte 100mg/1000mg SR tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin 100mg/1000mg extended-release tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed metformin-associated lactic acidosis (MALA), this rare side effect necessitates caution in patients with kidney impairment, the elderly, or those consuming significant alcohol. Symptoms may present as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitaglo M Forte 100mg/1000mg sustained-release tablets can lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency can result in anemia and neurological complications, manifesting as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, proposed by some studies, include annual supplemental Vitamin B12.
Store this medication in its original, tightly sealed container or packaging, following all storage instructions provided on the label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitaglo M Forte 100mg/100...
180
MRP 209
13% off